RxDoctor Payments DataLook up a doctor →

John Browning, MD

Dermatology · San Antonio, TXNPI 1124181615

Payments from drug & device makers

$10,745,177in general payments, 2019–2025

Across 3,218 payments — averaging $3339.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3.2M
  • Eli Lilly$1.7M
  • Janssen Research & Development, LLC$1.1M
  • Regeneron$862K
  • Sanofi US Services Inc.$701K
  • Pfizer$604K
  • plus $2.6M from 54 others
$53,975in research payments, 2019–2025

Across 34 payments — averaging $1587.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$34K
  • Novartis$11K
  • Regeneron$4K
  • Pfizer$3K
  • Bausch Health US, LLC$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis57$3,175,907
Eli Lilly85$1,688,624
Janssen Research & Development, LLC239$1,064,673
Regeneron264$861,527
Sanofi US Services Inc.60$701,003
Pfizer256$604,345
Incyte Corporation151$381,494
Takeda Pharmaceuticals U.S.A., Inc.31$365,016
Dermavant Sciences, Inc.1,001$333,330
AbbVie194$314,655
E.r. Squibb & Sons, L.L.C.42$213,033
Sun Pharmaceutical Industries Inc.73$160,513
Amgen18$155,746
LEO Pharma AS18$108,937
Bausch Health US, LLC15$104,525
Arcutis Biotherapeutics, Inc.49$89,595
Galderma Laboratories, L.p.117$76,674
Regeneron Healthcare Solutions, Inc.94$62,395
Krystal Biotech Inc76$54,890
UCB SA7$51,452
Amryt Pharma Holdings Ltd32$39,641
Galderma Research & Development, LLC4$28,392
GSK10$22,382
Vanda Pharmaceuticals Inc.9$21,188
Amicus Therapeutics, Inc.4$15,339
Sanofi49$14,035
Pierre Fabre Pharmaceuticals, Inc.18$11,550
Dermira, Inc.5$5,160
Chiesi USA, Inc.3$4,010
LEO Pharma Inc.36$3,313
Verrica Pharmaceuticals Inc.8$3,114
Bristol Myers Squibb3$2,784
Johnson & Johnson49$1,085
Organon12$894
Nobelpharma America, LLC5$862
Lilly USA, LLC37$859
UCB, Inc.19$539
Ortho Dermatologics, A Division Of Bausch Health US, LLC13$279
Revance Therapeutics, Inc.7$236
Boehringer Ingelheim6$185
Kerecis Limited10$144
Aclaris Therapeutics, Inc.2$142
AstraZeneca1$120
Biofrontera Inc.5$89
Genentech USA, Inc.5$76
Fresenius Kabi USA, LLC3$71
Mayne Pharma Commercial LLC3$59
VYNE Pharmaceuticals Inc.1$53
Cipher Pharmaceuticals US LLC1$28
EPI Health, LLC1$25
Taro Pharmaceuticals USA, Inc.1$25
Almirall LLC1$24
Botanix SB Inc1$22
Octapharma USA, Inc.1$20
Kyowa Kirin, Inc.1$18
Sandoz1$18
Strata Skin Sciences, Inc.1$17
Medimetriks Pharmaceuticals, Inc.1$15
KCI USA, Inc.1$14
Mylan Pharmaceuticals Inc.1$12

How this compares

$10,745,177 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Medicare billing

Part B allowed, 2024
$647,836
Medicare patients
1,552
Services billed
27,989

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →